COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics Announces Completion of Pure Sunfarms CAD$20 Million Credit Facility with Bank of Montreal and Farm Credit Canada
13/02/2019
VICTORIA, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high- [...]
XOMA Receives $5.5 Million Payment from Rezolute
13/02/2019
EMERYVILLE, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today it has received a $5.5 million payment from Rezolute, Inc., related to the Companies’ 2017 license agreement, as most [...]
ContraFect Announces Oral Presentation at the 2019 Gordon Research Conference on Mechanisms and Application: Realizing the Potential of Antimicrobial Host Defense Peptides for Human and Veterinary Medicine
13/02/2019
YONKERS, N.Y., Feb. 13, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations
13/02/2019
Issuance of new patents strengthens the intellectual property around Melt Pharmaceuticals’ flagship drug candidate and potential label extensions SAN DIEGO and BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Melt [...]
Natus Medical Announces Fourth Quarter and Full Year 2018 Financial Results
13/02/2019
Reports record fourth quarter revenue of $141.0 million Reports fourth quarter GAAP loss per share of $0.35 and non-GAAP earnings per share of $0.43 Provides annual revenue and earnings guidance for 2019 PLEASANTON, [...]
Nash Pharmaceuticals to Present Data on Its Inflammatory Bowel Disease Research Program at The Digestive Disease Week Annual Conference
13/02/2019
VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH ) (CNSX: BTH ) (FRANKFURT: BTI) (OTCQB: BTHCF ) (the “ Company [...]
Cambrex Reports Fourth Quarter and Full Year 2018 Financial Results
13/02/2019
- Acquired Avista Pharma Solutions, broadening capabilities, enhancing revenue growth and expanding customer base - - Conference call at 8:30 a.m. ET on February 13, 2019 - EAST RUTHERFORD, N.J., Feb. 13, 2019 (GLOBE [...]
Natus Medical Announces Continued Board Refreshment with Two New Independent Directors
13/02/2019
PLEASANTON, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) announced today a significant refreshment of its board of directors with the appointment of Alice D. Schroeder, former CEO [...]
AroCell's CEO share his views on the company in a video interview
13/02/2019
Today AroCell publishes a short video interview with Michael Brobjer, CEO, and his reflections on his first months at Arocell. The video is available through the link below, AroCell website, and on Financial Hearings [...]
Sensorion to Present New SENS-401 Data at ARO 2019 MidWinter Meeting, Feb. 9-13, 2019
13/02/2019
Two poster presentations to show growing evidence base for SENS-401 in inner ear disease MONTPELLIER, France, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN / PEA-PME eligible) , a biotech company [...]
PCI Biotech: Fourth quarter and preliminary 2018 results
13/02/2019
Oslo (Norway), 13 February 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim fourth quarter and preliminary 2018 result. Please find enclosed the report and [...]
ALS related metabolic pathway discovered by Sheffield scientists using Biolog technology
13/02/2019
Discovery could open doorway to new treatment SHEFFIELD, United Kingdom and HAYWARD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Researchers at the University of Sheffield have identified a new pathway that is disrupted [...]
MacroGenics Announces Pricing of Public Offering of Common Stock
13/02/2019
ROCKVILLE, MD, Feb. 12, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent [...]
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/02/2019
WALTHAM Mass. and CRESTWOOD, Ky., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Tabula Rasa HealthCare Announces Closing of Offering of 1.75% Convertible Notes and Exercise in Full of Option to Purchase Additional Notes
12/02/2019
MOORESTOWN, N.J., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) (“TRHC”) today announced the closing of its previously announced offering of $325 million principal amount of 1.75% [...]
National Research Corporation Announces Fourth Quarter and Year-End 2018 Results
12/02/2019
Voice of Customer Platform Achieves Major Milestone LINCOLN, Neb., Feb. 12, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced results for the fourth quarter and year end 2018. Voice of [...]
Medexus inscrit les débentures convertibles non garanties d’octobre 2018 à la Bourse de croissance TSX
12/02/2019
MONTRÉAL, 12 févr. 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (anciennement Pediapharm Inc.) (la « Société ») (TSXV : MDP, OTCQB : PDDPF) a annoncé aujourd’hui que les débentures convertibles non garanties à [...]
VistaGen Therapeutics Reports Fiscal 2019 Third Quarter Financial Results
12/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for treating depression and other [...]

Pages